Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
Fig 1 C I
Solini GE et al. (2020) |
Xla WT + notch1 ICD [unilateral]
NF 28 |
|
||||||
Fig 4 E
Solini GE et al. (2020) |
Xla WT + notch1 ICD [unilateral]
NF 30 |
|
||||||
Fig 4 G H
Solini GE et al. (2020) |
Xla WT + notch1 ICD [unilateral]
NF 30 |
|
||||||
Fig.2.j
Vega-López GA et al. (2015) |
Xla Wt + canotch1-GR
NF16 (in situ hybridization) |
|
||||||
Fig.2.n
Vega-López GA et al. (2015) |
Xla Wt + canotch1-GR
NF16 (in situ hybridization) |
|
||||||
Fig 1. R, S
Nieber F et al. (2013) |
Xla Wt + canotch1
NF15 (in situ hybridization) |
|
||||||
fig.4.i
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF13 (in situ hybridization) |
|
||||||
fig.S1.b, c, e, f
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF13-21 (in situ hybridization) |
|
||||||
fig.1.f
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF14 (in situ hybridization) |
|
||||||
fig.2.c, c^1
Peyrot SM et al. (2011) |
Xla Wt + canotch1
NF16 (in situ hybridization) |
|